Francois Xavier Frapaise MD | CMO
Merck Biosimilars

Francois Xavier Frapaise MD, CMO, Merck Biosimilars

35 years of international (US/EU) pharmaceutical industry experience including senior/
C-level Positions (CEO, VP Medical Affairs and R&D, CSO, and CMO) in Drug
Development, Pharmacovigilance, Medical Affairs and Strategic
Marketing/Strategic Planning
Currently VP Clinical Development, Clinical Operations, Pharmacovigilance and Medical Affairs at Merck Biosimilars in Aubonne (CH)
Visiting Professor :Loyola University Medical Center Maywood IL
US/French citizenship
Hobbies: travel, languages, social sciences


Biosimilars Day 2 - Wednesday 1st November 2017 @ 17:00

Patients & biosimilars – the most important stakeholder

  • Discover novel approaches to including the patient vision in trial design
  • Understand the role of the patient post-commercialization
  • Learn why Merck Biosimilars works with a patient advisory board to include the patient voice at every stage of biosimilar development)

back to speakers